We are live on ! Find out more
ADIL

Adial Pharmaceuticals
ADIL

18 hedge funds and large institutions have $3.04M invested in Adial Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $1.85M → $3.04M (+$1.19M)

0% more funds holding

Funds holding: 18 → 18 (0)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$900K
2
State Street
State Street
Massachusetts
+$119K
3
VF
Virtu Financial
New York
+$76.1K
4
GG
Golden Green
South Carolina
+$60.8K
5
Northern Trust
Northern Trust
Illinois
+$53.2K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$132K
2
Barclays
Barclays
United Kingdom
-$38K
3
BlackRock
BlackRock
New York
-$24.3K
4
Creative Planning
Creative Planning
Kansas
-$24K
5
UBS Group
UBS Group
Switzerland
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.49M +$900K +592 +172%
BlackRock
2
BlackRock
New York
$499K -$24.3K -16 -5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$225K +$24.3K +16 +13%
State Street
4
State Street
Massachusetts
$125K +$119K +78 New
PAG
5
Private Advisor Group
New Jersey
$93K – – –
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$80K – – –
VF
7
Virtu Financial
New York
$79K +$76.1K +50 New
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$74K +$16.7K +11 +31%
OC
9
Oppenheimer & Co
New York
$71K +$33.5K +22 +96%
Brown Advisory
10
Brown Advisory
Maryland
$66K – – –
GG
11
Golden Green
South Carolina
$63K +$60.8K +40 New
Northern Trust
12
Northern Trust
Illinois
$56K +$53.2K +35 New
Citadel Advisors
13
Citadel Advisors
Florida
$52K -$132K -87 -73%
RW
14
Rede Wealth
Virginia
$39K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$21K – – –
Wells Fargo
16
Wells Fargo
California
$2K – – –
Morgan Stanley
17
Morgan Stanley
New York
$1K -$10.6K -7 -88%
TRCT
18
Tower Research Capital (TRC)
New York
$1K -$1.52K -1 -50%
Barclays
19
Barclays
United Kingdom
– -$38K -25 Closed
Creative Planning
20
Creative Planning
Kansas
– -$24K -16 Closed
UBS Group
21
UBS Group
Switzerland
– -$11K -7 Closed
WCM
22
Wealthcare Capital Management
Virginia
– -$1K -1 Closed

ADIL Hedge Fund Activity: Q2 2021 in Review

18 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q2 2021, worth a combined $3.04M — up 64% from $1.85M a quarter earlier.

Fund positioning in ADIL was balanced in Q2 2021: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $900K. The largest seller was Citadel Advisors, cutting an estimated $132K.

  • 18 institutional investors held Adial Pharmaceuticals (ADIL) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $3.04M of Adial Pharmaceuticals stock for Q2 2021, up 64% quarter-over-quarter.
  • 4 funds opened new Adial Pharmaceuticals positions in Q2 2021 and 4 closed out, a net change of 0 holders.
  • The largest Adial Pharmaceuticals buyer in Q2 2021 was Vanguard Group, an estimated $900K added.
  • The largest Adial Pharmaceuticals seller in Q2 2021 was Citadel Advisors, an estimated $132K sold.

Based on aggregated 13F filings for Q2 2021.